NU SKIN ENTERPRISES, INC.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $1.49B $1.73B $1.97B $2.23B $2.70B $2.58B $2.42B
Cost of Revenue $453.8M $550.2M $611.9M $630.9M $675.2M $658.0M $581.4M
Gross Profit $1.03B $1.18B $1.36B $1.59B $2.02B $1.92B $1.84B
Gross Margin 69.4% 68.2% 68.9% 71.7% 75.0% 74.5% 76.0%
Operating Expenses
Research & Development $10.8M $13.0M $22.6M $23.3M $27.2M $23.3M $30.1M
SG&A Expense $432.1M $479.0M $546.9M $555.8M $654.4M $636.5M $616.0M
Operating Income $65.8M $-151.6M $48.3M $110.8M $234.0M $257.6M $267.4M
Operating Margin 4.4% -8.8% 2.5% 5.0% 8.7% 10.0% 11.0%
Interest Expense $25.6M $13.5M $11.0M $13.1M $19.2M
Pretax Income $196.2M $-175.1M $26.6M $89.0M $232.5M $256.2M $255.2M
Income Tax Expense $36.0M $-28.5M $18.0M $-15.8M $85.2M $64.9M $81.6M
Net Income $160.2M $-146.6M $8.6M $104.8M $147.3M $191.4M $173.6M
Net Margin 10.8% -8.5% 0.4% 4.7% 5.5% 7.4% 7.2%
EPS (Basic) $3.25 $-2.95 $0.17 $2.10 $2.93 $3.66 $3.13
EPS (Diluted) $3.18 $-2.95 $0.17 $2.07 $2.86 $3.63 $3.10
Shares Outstanding (Basic) 48.1M 49.3M 49.7M 49.7M 50.0M 50.2M 52.3M 55.5M
Shares Outstanding (Diluted) 48.1M 50.3M 49.7M 49.9M 50.5M 51.4M 52.8M 55.9M
Dividends Per Share
← Newer Page 1 of 3 Older →